Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...

Compared with placebo, fostamatinib did not increase the number of oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.

Infectious or chronic diseases such as long COVID, Alzheimer’s disease and traumatic brain injury can cause inflammation in ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The bill's sponsor said that restriction was “an error,” and that she intends to change it if it were to move forward in the ...

This update is based on a press release statement from Invivyd, Inc. The company's stock has experienced significant volatility, with a 16.39% gain in the past week despite a 64.17% decline over six ...

Invivyd (IVVD) announced the submission to the U.S. Food and Drug Administration, FDA, of an updated immunobridging analysis of pemivibart as ...

SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that it has ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

It’s been estimated that about 400 million people worldwide have had long COVID. Some researchers say that number is much ...